Health

FDA Approves Penpulimab-kcqx for the Treatment of Advanced Nasopharyngeal Carcinoma

DailyTrendDailyTrend
Apr 28, 2025 - 19:00
 0  2
FDA Approves Penpulimab-kcqx for the Treatment of Advanced Nasopharyngeal Carcinoma
HONG KONG, April 24, 2025 -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in combination with...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

New Implant Offers Hope for Easing Rheumatoid Arthritis

New Implant Offers Hope for Easing Rheumatoid Arthritis

DailyTrend Jul 31, 2025  0  0

FDA Approves Vizz (aceclidine ophthalmic solution) for the Treatment of Presbyopia

FDA Approves Vizz (aceclidine ophthalmic solution) for ...

DailyTrend Aug 4, 2025  0  0

Trump Announces Health Care Records System for Consumers

Trump Announces Health Care Records System for Consumers

DailyTrend Jul 31, 2025  0  0

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the F...

DailyTrend Jul 30, 2025  0  0

Continuous Ventilator Correction: Philips Respironics Updates Use Instructions for BiPAP A30, A40, and V30 Devices Due to Interruptions and/or Loss of Therapy

Continuous Ventilator Correction: Philips Respironics U...

DailyTrend Aug 4, 2025  0  0

Sobi Announces U.S. Food and Drug Administration Approves Doptelet (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)

Sobi Announces U.S. Food and Drug Administration Approv...

DailyTrend Jul 29, 2025  0  0